Skip to main content

Table 3 Univariable analysis of RLNI pre- and post-PSM

From: Non-energy devices to dissect recurrent laryngeal nerve lymph nodes of non-small cell lung cancer under video-assisted thoracic surgery

 

RLNI (pre-PSM)

 

RLNI (post-PSM)

 
 

Yes (n=37)

No (n=151)

P value

Yes (n=24)

No (n=24)

P value

Dissection device

      

 Energy

25 (13.30%)

67 (35.64%)

0.016

11 (22.92%)

3 (6.28%)

0.008

 Non-energy

12 (6.38%)

84 (44.69%)

 

13 (27.08%)

21 (43.75%)

 

Side of primary

      

 Left

26 (13.83%)

59 (31.38%)

0.001

8 (16.67%)

8 (16.67%)

< 0.001

 Right

11 (5.85%)

92 (48.94%)

 

16 (33.33%)

16 (33.33%)

 

Age (years)

      

 < 60

20 (10.64%)

61 (32.45%)

0.143

12 (25.00%)

16 (33.33%)

0.506

 > 60

17 (9.04%)

90 (47.87%)

 

12 (25.00%)

8 (16.67%)

 

Gender

      

 Male

22 (11.70%)

97 (51.60%)

0.704

16 (33.33%)

15 (31.25%)

0.806

 Female

15 (7.98%)

54 (28.72%)

 

8 (16.67%)

9 (18.75)

 

FEV1 (L)

      

 < 2

23 (12.23%)

59 (31.38%)

0.016

13 (27.08%)

15 (31.25%)

0.012

 ≥ 2

14 (7.45%)

92 (48.94%)

 

11 (22.92%)

9 (18.75)

 

BMI

      

 < 24

18 (9.57%)

96 (51.06%)

0.132

11 (22.92%)

11 (22.92%)

0.011

 ≥ 24

19 (10.11%)

55 (29.26%)

 

13 (27.08%)

13 (27.08%)

 

Operative time (min)

      

 < 150

11 (5.85%)

74 (39.36%)

0.043

16 (33.33%)

12 (25.00%)

0.022

 ≥ 150

26 (13.83%)

77 (40.96%)

 

8 (16.67%)

12 (25.00%)

 

Location of primary

      

 Peripheral

28 (14.89%)

121 (64.36%)

0.651

18 (37.50%)

16 (33.33%)

0.901

 Central

9 (4.79%)

30 (15.96%)

 

6 (12.50%)

8 (16.67%)

 

Stage

      

 Early

21 (11.17%)

113 (60.11%)

0.042

8 (16.67%)

6 (12.50%)

0.056

 Advanced

16 (8.51%)

38 (20.21%)

 

16 (33.33%)

18 (37.50%)

 
  1. BMI body mass index, FEV1 forced expiratory volume in 1 second, RLNI recurrent laryngeal nerve injury, PSM propensity scores matching